Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 1.680 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Seelos Therapeutics Inc | SEEL | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,0731 | 8,06% | 0,98 | 14:19:09 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,9069 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 14 | 1.680 | - | 0,8814 - 398,40 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 14:17:59 | formt | 500 | US$ 0,98 | USD |
Finanzwerte SEEL
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 12,45M | 13,68M | - | 2,2M | -37,88M | -2,77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Seelos Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 14.6.2024 | 22:06 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 05.6.2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 31.5.2024 | 22:30 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 21.5.2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20.5.2024 | 22:16 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 16.5.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.5.2024 | 17:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.5.2024 | 14:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 06.3.2024 | 23:32 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 06.3.2024 | 22:50 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 01.3.2024 | 23:39 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 06.2.2024 | 23:26 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
Forum Seelos Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
SEEL Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 1,09 | 1,17 | 0,8814 | 0,9665651 | 165.324 | -0,11 | -10,09% |
| 1 Monat | 1,96 | 2,02 | 0,8814 | 1,20 | 119.361 | -0,98 | -50,00% |
| 3 Monate | 4,208 | 5,44 | 0,8814 | 2,80 | 348.320 | -3,23 | -76,71% |
| 6 Monate | 13,04 | 15,44 | 0,8814 | 6,39 | 398.430 | -12,06 | -92,48% |
| 1 Jahr | 235,92 | 398,40 | 0,8814 | 70,04 | 2.026.663 | -234,94 | -99,58% |
| 3 Jahre | 768,00 | 793,80 | 0,8814 | 272,98 | 1.772.624 | -767,02 | -99,87% |
| 5 Jahre | 542,40 | 1.584,00 | 0,8814 | 583,94 | 2.290.363 | -541,42 | -99,82% |
